Philippines - English - FDA (Food And Drug Administration)

stadapharm gmbh; importer: stada philippines, inc.; distributor: stada philippines, inc. - mesna - solution for injection (iv) - 100mg/ml (400mg/4ml)

Philippines - English - FDA (Food And Drug Administration)

stadapharm gmbh; importer: stada philippines, inc.; distributor: globo asiatico enterprises, inc. - mesna - solution for injection (iv) - 100mg/ml (400mg/4ml)

Ireland - English - HPRA (Health Products Regulatory Authority)

cell pharm gmbh - doxorubicin hydrochloride - solution for injection - 2 milligram(s)/millilitre - anthracyclines and related substances; doxorubicin

Philippines - English - FDA (Food And Drug Administration)

stadapharm gmbh; importer: stada philippines, inc.; distributor: stada philippines, inc. - exemestane - film-coated tablet - 25mg

Malta - English - Medicines Authority

stadapharm gmbh stadastraße 2-18 61118 bad vilbel, , germany - powder for solution for injection - bleomycin sulfate 15 iu - antineoplastic agents

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - lisinopril -

Israel - English - Ministry of Health

mbi pharma ltd., israel - ifosfamide - solution for infusion - ifosfamide 2 g / 50 ml - ifosfamide - • testicular tumours for combination chemotherapy in patients with advanced stage ii to iv tumours according to the tnm classification (seminomas and non-seminomas), which do not respond or adequately respond to initial chemotherapy.• cervical cancerpalliative cisplatin/ifosfamide combination chemotherapy (without any other combination partners) of cervical carcinoma, figo stage iv b (when curative therapy of the disease is not possible with surgery or radiotherapy) – as an alternative to palliative radiotherapy.• breast cancerfor palliative therapy in advanced, therapy-refractory or recurrent breast cancer.• non-small-cell lung cancerfor mono- or combination chemotherapy of patients with inoperable or metastatic tumours.• small-cell lung cancerfor combination chemotherapy.• soft-tissue sarcoma (incl. osteosarcoma and rhabdomyosarcoma)for mono- or combination chemotherapy of rhabdomyosarcoma or osteosarcoma after failure of standard therapies. for mono- or combination chemotherapy of other soft-tissue sarcoma

Israel - English - Ministry of Health

mbi pharma ltd., israel - ifosfamide - concentrate for solution for infusion - ifosfamide 5 g / 25 ml - ifosfamide - • testicular tumours for combination chemotherapy in patients with advanced stage ii to iv tumours according to the tnm classification (seminomas and non-seminomas), which do not respond or adequately respond to initial chemotherapy.• cervical cancerpalliative cisplatin/ifosfamide combination chemotherapy (without any other combination partners) of cervical carcinoma, figo stage iv b (when curative therapy of the disease is not possible with surgery or radiotherapy) – as an alternative to palliative radiotherapy.• breast cancerfor palliative therapy in advanced, therapy-refractory or recurrent breast cancer.• non-small-cell lung cancerfor mono- or combination chemotherapy of patients with inoperable or metastatic tumours.• small-cell lung cancerfor combination chemotherapy.• soft-tissue sarcoma (incl. osteosarcoma and rhabdomyosarcoma)for mono- or combination chemotherapy of rhabdomyosarcoma or osteosarcoma after failure of standard therapies. for mono- or combination chemotherapy of other soft-tissue sarcoma

Israel - English - Ministry of Health

mbi pharma ltd., israel - epirubicin hydrochloride - solution for injection - epirubicin hydrochloride 50 mg / 25 ml - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma (high doses), ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.

Israel - English - Ministry of Health

mbi pharma ltd., israel - cytarabine - solution for infusion - cytarabine 4000 mg / 80 ml - cytarabine - ara-cell® 4000 mg is indicated for induction and maintenance of clinical remission in patients with acute myeloid leukemia, acute non-lymphoblastic leukemias, acute lymphoblastic leukemias, blast crises of chronic myeloid leukemia, diffuse histiocytic lymphomas (non-hodgkin's lymphomas of high malignancy).